Mechanism of interaction of CC-1065 (NSC 298223) with DNA

D. H. Swenson, L. H. Li, L. H. Hurley, J. S. Rokem, G. L. Petzold, B. D. Dayton, T. L. Wallace, Laurence Hurley, W. C. Krueger

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

CC-1065 (NSC 298223), a potent new antitumor antibiotic produced by Streptomyces zelensis, interacts strongly with double-stranded DNA and appears to exert its cytotoxic effects through disruption of DNA synthesis. We undertook this study to elucidate the sites and mechanisms of CC-1065 interaction with DNA. The binding of CC-1065 to synthetic and native DNA was examined by differential circular dichroism or by Sephadex chromatography with photometric detection. The binding of CC-1065 with calf thymus DNA was rapid, being complete within 2 hr, and saturated at 1 drug per 7 to 11 base pairs. The interaction of CC-1065 with synthetic DNA polymers indicated a specificity for adenine- and thymine-rich sites. Agarose gel electrophoresis of CC-1065-treated supercoiled DNA showed that CC-1065 did not intercalate. Site exclusion studies using substitutions in the DNA grooves showed CC-1065 to bind primarily in the minor groove. CC-1065 did not cause DNA breaks; it inhibited susceptibility of DNA to nuclease S1 digestion. It raised the thermal melting temperature of DNA, and it inhibited the thiolium-induced unwinding of DNA. Thus, in contrast to many antitumor agents, CC-1065 stabilized the DNA helix. DNA helix overstabilization may be relevant to the mechanism of action of CC-1065.

Original languageEnglish (US)
Pages (from-to)2821-2828
Number of pages8
JournalCancer Research
Volume42
Issue number7
StatePublished - 1982
Externally publishedYes

Fingerprint

CC 1065
DNA
Nucleic Acid Denaturation
Superhelical DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Swenson, D. H., Li, L. H., Hurley, L. H., Rokem, J. S., Petzold, G. L., Dayton, B. D., ... Krueger, W. C. (1982). Mechanism of interaction of CC-1065 (NSC 298223) with DNA. Cancer Research, 42(7), 2821-2828.

Mechanism of interaction of CC-1065 (NSC 298223) with DNA. / Swenson, D. H.; Li, L. H.; Hurley, L. H.; Rokem, J. S.; Petzold, G. L.; Dayton, B. D.; Wallace, T. L.; Hurley, Laurence; Krueger, W. C.

In: Cancer Research, Vol. 42, No. 7, 1982, p. 2821-2828.

Research output: Contribution to journalArticle

Swenson, DH, Li, LH, Hurley, LH, Rokem, JS, Petzold, GL, Dayton, BD, Wallace, TL, Hurley, L & Krueger, WC 1982, 'Mechanism of interaction of CC-1065 (NSC 298223) with DNA', Cancer Research, vol. 42, no. 7, pp. 2821-2828.
Swenson DH, Li LH, Hurley LH, Rokem JS, Petzold GL, Dayton BD et al. Mechanism of interaction of CC-1065 (NSC 298223) with DNA. Cancer Research. 1982;42(7):2821-2828.
Swenson, D. H. ; Li, L. H. ; Hurley, L. H. ; Rokem, J. S. ; Petzold, G. L. ; Dayton, B. D. ; Wallace, T. L. ; Hurley, Laurence ; Krueger, W. C. / Mechanism of interaction of CC-1065 (NSC 298223) with DNA. In: Cancer Research. 1982 ; Vol. 42, No. 7. pp. 2821-2828.
@article{2538cfada5744247b6050f353c4d93cc,
title = "Mechanism of interaction of CC-1065 (NSC 298223) with DNA",
abstract = "CC-1065 (NSC 298223), a potent new antitumor antibiotic produced by Streptomyces zelensis, interacts strongly with double-stranded DNA and appears to exert its cytotoxic effects through disruption of DNA synthesis. We undertook this study to elucidate the sites and mechanisms of CC-1065 interaction with DNA. The binding of CC-1065 to synthetic and native DNA was examined by differential circular dichroism or by Sephadex chromatography with photometric detection. The binding of CC-1065 with calf thymus DNA was rapid, being complete within 2 hr, and saturated at 1 drug per 7 to 11 base pairs. The interaction of CC-1065 with synthetic DNA polymers indicated a specificity for adenine- and thymine-rich sites. Agarose gel electrophoresis of CC-1065-treated supercoiled DNA showed that CC-1065 did not intercalate. Site exclusion studies using substitutions in the DNA grooves showed CC-1065 to bind primarily in the minor groove. CC-1065 did not cause DNA breaks; it inhibited susceptibility of DNA to nuclease S1 digestion. It raised the thermal melting temperature of DNA, and it inhibited the thiolium-induced unwinding of DNA. Thus, in contrast to many antitumor agents, CC-1065 stabilized the DNA helix. DNA helix overstabilization may be relevant to the mechanism of action of CC-1065.",
author = "Swenson, {D. H.} and Li, {L. H.} and Hurley, {L. H.} and Rokem, {J. S.} and Petzold, {G. L.} and Dayton, {B. D.} and Wallace, {T. L.} and Laurence Hurley and Krueger, {W. C.}",
year = "1982",
language = "English (US)",
volume = "42",
pages = "2821--2828",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Mechanism of interaction of CC-1065 (NSC 298223) with DNA

AU - Swenson, D. H.

AU - Li, L. H.

AU - Hurley, L. H.

AU - Rokem, J. S.

AU - Petzold, G. L.

AU - Dayton, B. D.

AU - Wallace, T. L.

AU - Hurley, Laurence

AU - Krueger, W. C.

PY - 1982

Y1 - 1982

N2 - CC-1065 (NSC 298223), a potent new antitumor antibiotic produced by Streptomyces zelensis, interacts strongly with double-stranded DNA and appears to exert its cytotoxic effects through disruption of DNA synthesis. We undertook this study to elucidate the sites and mechanisms of CC-1065 interaction with DNA. The binding of CC-1065 to synthetic and native DNA was examined by differential circular dichroism or by Sephadex chromatography with photometric detection. The binding of CC-1065 with calf thymus DNA was rapid, being complete within 2 hr, and saturated at 1 drug per 7 to 11 base pairs. The interaction of CC-1065 with synthetic DNA polymers indicated a specificity for adenine- and thymine-rich sites. Agarose gel electrophoresis of CC-1065-treated supercoiled DNA showed that CC-1065 did not intercalate. Site exclusion studies using substitutions in the DNA grooves showed CC-1065 to bind primarily in the minor groove. CC-1065 did not cause DNA breaks; it inhibited susceptibility of DNA to nuclease S1 digestion. It raised the thermal melting temperature of DNA, and it inhibited the thiolium-induced unwinding of DNA. Thus, in contrast to many antitumor agents, CC-1065 stabilized the DNA helix. DNA helix overstabilization may be relevant to the mechanism of action of CC-1065.

AB - CC-1065 (NSC 298223), a potent new antitumor antibiotic produced by Streptomyces zelensis, interacts strongly with double-stranded DNA and appears to exert its cytotoxic effects through disruption of DNA synthesis. We undertook this study to elucidate the sites and mechanisms of CC-1065 interaction with DNA. The binding of CC-1065 to synthetic and native DNA was examined by differential circular dichroism or by Sephadex chromatography with photometric detection. The binding of CC-1065 with calf thymus DNA was rapid, being complete within 2 hr, and saturated at 1 drug per 7 to 11 base pairs. The interaction of CC-1065 with synthetic DNA polymers indicated a specificity for adenine- and thymine-rich sites. Agarose gel electrophoresis of CC-1065-treated supercoiled DNA showed that CC-1065 did not intercalate. Site exclusion studies using substitutions in the DNA grooves showed CC-1065 to bind primarily in the minor groove. CC-1065 did not cause DNA breaks; it inhibited susceptibility of DNA to nuclease S1 digestion. It raised the thermal melting temperature of DNA, and it inhibited the thiolium-induced unwinding of DNA. Thus, in contrast to many antitumor agents, CC-1065 stabilized the DNA helix. DNA helix overstabilization may be relevant to the mechanism of action of CC-1065.

UR - http://www.scopus.com/inward/record.url?scp=0019990978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019990978&partnerID=8YFLogxK

M3 - Article

C2 - 7083173

AN - SCOPUS:0019990978

VL - 42

SP - 2821

EP - 2828

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -